UnitedHealth's Strategy to Calm Investors Amid Profit Declines

Stephen Hemsley, Chairman and CEO, will soon put his leadership to the test as he reports on UnitedHealth's earnings, aimed at regaining investor trust.

Ever since mid-May, the health giant's stock has plummeted, now predicted to have its worst year in over ten years. This downturn is due to losses in its primary Medicare program and optometry practices, combined with an unexpected CEO shift, which saw Stephen Hemsley returning to the helm after Andrew Witty's exit, prompting the suspension of financial forecasts. Meanwhile, their Medicare billing practices are under DOJ investigation.

Mizuho Securities analyst Ann Hynes refers to UnitedHealth's current challenges as being caught in a 'perfect storm.' Following Hemsley's pledge last June to 'earn back your trust and confidence,' investors are keenly awaiting his strategy to navigate through these turbulent times.

Focus on 2025 Forecasts

Outside of immediate financial results, the spotlight is on UnitedHealth's full-year projections, with Hemsley indicating an update on 2025 earnings following earlier deferments. Consensus estimates from LSEG project adjusted earnings at $21.26 per share, ranging between a low of $18 and a high of $26.44.

RBC Capital's Ben Hendrix sets his own prediction at $23.36, sharing that, although he remains more hopeful based on management insights, investor sentiment is largely pessimistic.

He pointed out that confidence in Medicare Advantage profitability remains optimistic, yet stakeholders worry about narrower margins in OptumHealth and escalating medical costs.

Probing Medicare Advantage and Optum Health Trajectory

Attention centers around how UnitedHealth intends to stabilize its physician practice sector, Optum Health, which historically strengthened its Medicare Advantage edge by employing a large workforce to serve its clientele.

Baird Analyst Michael Ha noted that UnitedHealth's past allure was its ability to direct Medicare funds towards its own network, extracting previously inaccessible margins.

However, Optum Health's profits sharply fell in the first quarter, attributed to Medicare reimbursement revamps known as V28, which have limited billing for additional services.

The V28 regulation has tightened codes, restricting additional listings that previously justified higher reimbursements. Mizuho’s Ann Hynes observed that these stricter rules signify a fundamental margin shift for Optum Health.

As many competitors adjusted to these changes in 2024, UnitedHealth seemed unprepared for Optum Health's declining profits. Although they foresaw the challenges, they struggled to find countermeasures, raising concerns about the future of their economic units.

Legal and Regulatory Concerns

In an anticipatory move before releasing financial results, UnitedHealth acknowledged ongoing DOJ investigations into its Medicare billing procedures.

While cooperating with these inquiries, CEO Hemsley reflects upon similar allegations rebuffed successfully during the prior administration, downplaying potential outcomes as exaggerated.

Yet, public opinion against health insurers has intensified following a fatal incident involving a UnitedHealth executive, spotlighting industry practices.

Critics like former industry whistleblower Wendell Potter predict sustained scrutiny given congressional interest driven by shared experiences of high costs in health policies.

In June, UnitedHealth announced an external audit reviewing its health insurance and pharmacy services to enhance transparency and accountability, although detailed findings are expected later in the year.

The stock’s reaction suggests exaggerated fears of regulatory consequences, a sentiment dismissed by analysts who expect financial settlements as a more probable solution.